Australian company visits to jointly explore animal tumors

New Opportunities in the Ablation Field

On December 2, 2024, our company welcomed a delegation from the Australian company. The two sides focused on animal tumor ablation technology, products and domestic and foreign markets, and carried out in-depth and fruitful exchanges and discussions. This event has injected new impetus into international cooperation in the field of pet medical care and opened a new journey.

Visit the work environment

Upon their first visit, the delegation toured the company's overall architecture and facilities. From advanced R&D facilities to a well-equipped production environment, every detail showcased the company's strong capabilities and professional expertise in the field of pet healthcare, earning unanimous praise and high recognition from the delegation members.

Analyzing and exchanging information about domestic and foreign markets

Following this, both parties commenced core discussions, focusing on a comprehensive and detailed analysis of the current status and future development trends of pet tumor ablation systems in domestic and international markets. Leveraging our extensive experience and keen insights accumulated in the domestic market, our company provided an in-depth analysis of the scale, growth trend, consumer demand characteristics, and policy environment impacts of the domestic pet tumor ablation market.

Meanwhile, the Australian company, with its broad international perspective, shared valuable information on the market landscape, technological preferences, competitive dynamics, and regulatory requirements in the field of pet tumor ablation, particularly in Australia and Europe. Through the exchange of ideas and data, both parties accurately identified market pain points and potential opportunities, reaching a deep consensus on several key areas, including technological innovation directions, product optimization and upgrade paths, and market expansion strategies. They also engaged in a positive and constructive discussion on the possibility of future collaboration to jointly explore overseas markets, outlining a clear blueprint for subsequent substantive cooperation.

Observe product demonstration

Finally, the delegation watched with great interest a live demonstration of our company's animal tumor microwave ablation system. During the demonstration, our professional technicians skillfully operated the system, accurately demonstrating its high efficiency, precision, and safety in the treatment of pet tumors. Its outstanding clinical application results impressed the delegation members, who gave it high praise and full affirmation.

Summarize

The successful holding of this study tour and exchange activity has not only greatly deepened the mutual understanding and trust between the two parties in the field of animal tumor ablation, but also laid a solid foundation for both parties to work together in the future to promote the globalization of animal tumor treatment technology and create more benefits for the global pet healthcare industry. Our company will also take this opportunity to steadfastly uphold the principles of open cooperation and innovation, continue to cultivate the pet healthcare field, constantly explore and move forward, and strive to provide pets with higher-quality, more efficient, and safer medical solutions, contributing more to the cause of pet health.